AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.

Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

Shawn Kortes, known for his philanthropic work in the community, started dialysis this year and is searching for a kidney ...

Northern Scotland has one of the highest rates of Huntington's disease in the world, according to a new study. Huntington's ...

"Pridopidine shows long-term sustained efficacy up to 2 years, and there's significant long-term benefit confirmed compared ...

One of the areas of the brain where these cells congregate is the ventricular zone, which is adjacent to the striatum, a region of the brain devastated by Huntington’s disease. The idea that the adult ...

Huntington's disease is a rare and fatal disease characterized ... Massachusetts since 2012. Background to the Else Kröner Fresenius Prize for Medical Research The Else Kröner Fresenius Prize ...

Home > Pressemitteilung: The 2025 Else Kröner Fresenius Prize ...

Research in a mouse model of Huntington’s disease has shown that the adult brain can generate new neurons that integrate into key motor circuits. Building on previous work, the new findings ...